BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: DuPont HL, Galler G, Garcia-Torres F, Dupont AW, Greisinger A, Jiang ZD. Travel and travelers' diarrhea in patients with irritable bowel syndrome. Am J Trop Med Hyg 2010;82:301-5. [PMID: 20134008 DOI: 10.4269/ajtmh.2010.09-0538] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Tuteja AK. Deployment-Associated Functional Gastrointestinal Disorders: Do We Know the Etiology? Dig Dis Sci 2011;56:3109-11. [DOI: 10.1007/s10620-011-1856-y] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Hong KS, Kim JS. Rifaximin for the treatment of acute infectious diarrhea. Therap Adv Gastroenterol 2011;4:227-35. [PMID: 21765867 DOI: 10.1177/1756283X11398734] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
3 Lindsay L, DuPont HL, Moe CL, Alberer M, Hatz C, Kirby AE, Wu HM, Verstraeten T, Steffen R. Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol. BMC Infect Dis 2018;18:605. [PMID: 30509202 DOI: 10.1186/s12879-018-3461-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Soonawala D, Vlot JA, Visser LG. Inconvenience due to travelers' diarrhea: a prospective follow-up study. BMC Infect Dis 2011;11:322. [PMID: 22099542 DOI: 10.1186/1471-2334-11-322] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
5 Nair P, Okhuysen PC, Jiang ZD, Carlin LG, Belkind-Gerson J, Flores J, Paredes M, DuPont HL. Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med 2014;21:153-8. [PMID: 24621006 DOI: 10.1111/jtm.12114] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
6 Dupont HL. Gastrointestinal infections and the development of irritable bowel syndrome. Curr Opin Infect Dis 2011;24:503-8. [PMID: 21844806 DOI: 10.1097/QCO.0b013e32834a962d] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
7 Clark SD, Sidlak M, Mathers AJ, Poulter M, Platts-Mills JA. Clinical Yield of a Molecular Diagnostic Panel for Enteric Pathogens in Adult Outpatients With Diarrhea and Validation of Guidelines-Based Criteria for Testing. Open Forum Infect Dis 2019;6:ofz162. [PMID: 31041357 DOI: 10.1093/ofid/ofz162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
8 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
9 Ghoshal UC, Shukla R, Ghoshal U, Gwee KA, Ng SC, Quigley EM. The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam. 2012;2012:151085. [PMID: 22577594 DOI: 10.1155/2012/151085] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 8.5] [Reference Citation Analysis]
10 Hill DR, Beeching NJ. Travelersʼ diarrhea: . Current Opinion in Infectious Diseases 2010;23:481-7. [DOI: 10.1097/qco.0b013e32833dfca5] [Cited by in Crossref: 79] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
11 Dupont HL. Chronic Complications After Travelers' Diarrhea. J Travel Med 2013;20:273-4. [DOI: 10.1111/jtm.12045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
12 Lever RA, Tapper L, Skarbek S, Chiodini PL, Armstrong M, Bailey RL. Predictors of aetiology and outcomes of acute gastrointestinal illness in returning travellers: a retrospective cohort analysis. BMC Infect Dis 2021;21:599. [PMID: 34162344 DOI: 10.1186/s12879-021-06223-3] [Reference Citation Analysis]
13 Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol. 2012;12:55. [PMID: 22639930 DOI: 10.1186/1471-230x-12-55] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
14 Darkoh C, Comer L, Zewdie G, Harold S, Snyder N, Dupont HL. Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One. 2014;9:e93144. [PMID: 24667736 DOI: 10.1371/journal.pone.0093144] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
15 Porter CK, Gloor K, Cash BD, Riddle MS. Risk of Functional Gastrointestinal Disorders in U.S. Military Following Self-Reported Diarrhea and Vomiting During Deployment. Dig Dis Sci 2011;56:3262-9. [DOI: 10.1007/s10620-011-1762-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
16 Connor BA. Post-Infectious Sequelae of Travelers’ Diarrhea: Reactive Arthritis, Guillain-Barré Syndrome, and Irritable Bowel Syndrome. Curr Trop Med Rep 2016;3:102-7. [DOI: 10.1007/s40475-016-0080-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]